1246P PIT-3: A multicenter phase II trial of erlotinib induction followed by surgery in stage IIIA (N2) EGFR mutated non-small cell lung cancer
| Autor: | Takamochi, K., Suzuki, K., Tsuboi, M., Niho, S., Oyamada, S., Yamaguchi, T., Tanaka, F., Maniwa, Y., Shiono, S., Ito, H., Haruki, T., Suzuki, H., Ikeda, N., Watanabe, H., Okada, M. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S797-S797 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|